In the spring of 1968, members of my laboratory team were looking for new
Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.
View the original on the official releaseDocument text
Text is machine OCR and may contain errors. Confirm against the original source above.
CHAPTER 5:
SOME ENTHEOGENIC ENTROPIES
In the spring of 1968, members of my laboratory team were looking for new
brain metabolic pathways of the essential amino acid tryptophan, the dietary
precursor of the human mood, sleep and libidinal neurotransmitter, serotonin. After
struggling for several months to identify an apparently new compound, which turned
out not to be new but only new in the brain, we collected evidence for a human
brain enzyme that could catalyze the production of an LSD-like hallucinogen,
dimethyltryptamine, DMT. Tracing its metabolic origins, we found that DMT was
derived from tryptamine, a common metabolite of the essential and omnipresent
amino acid, tryptophan. This enzyme and its metabolic product were located in
highest concentrations in brain stem systems that influence the neural regulation of
the heart, blood pressure, temperature, breathing, vomiting and primitive approach-
avoidance behavior. It was also found in limbic brain nuclei thought to modulate the
emotional coloring of perception and thought. Richard Wyatt, working at the
National Institutes of Mental Health found DMT in the urine of schizophrenic
humans. He also showed that DMT increased significantly if tryptamine’s normal
pathway for degradation was blocked by monoamine oxidase inhibitors, such as
87
HOUSE_OVERSIGHT_013587
Have a question about what this document contains?
Ask the documents